Envestnet Portfolio Solutions »

Supernus Pharmaceuticals shares owned by Envestnet Portfolio Solutions

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Envestnet Portfolio Solutions from 13F filings

Historical chart of Envestnet Portfolio Solutions investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Envestnet Portfolio Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Envestnet Portfolio Solutions

Quarter filed Position value Share count Share price at filing
2023-12-31 $267k 9.2k 28.94

More positions owned by Envestnet Portfolio Solutions

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr National Mun Etf (MUB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ishares Tr Rus Tp200 Vl Etf (IWX)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus Mdcp Val Etf (IWS)
Trust For Professional Man Activepassive Us (APUE)

View all positions for Envestnet Portfolio Solutions

Top funds holding Supernus Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Jennifer Ranahan
Congress Asset Management
Ashford Capital Management
Victory Capital Management
Charles Schwab Investment Management
Rice Hall James & Associates
T. Rowe Price Associates
Bank of New York Mellon
Bank of America Corporation
Tributary Capital Management
Mutual Of America Capital Management
Principal Financial Group
Norges Bank Investment Management

View all funds holding Supernus Pharmaceuticals